Search Results for agency_names:"Centers for Disease Control and Prevention"

The Centers for Disease Control and Prevention (CDC) is awarding around $1.5 million, with a total of about $7.5 million expected over five years, to the University of Oslo. This funding will help improve global health by enhancing public health surveillance and response systems worldwide, building capacity to better detect and respond to disease outbreaks. The project focuses on improving the DHIS2 software, a critical tool for public health data management, which is uniquely maintained by the University of Oslo. The award period runs from September 2025 to September 2030.

The Centers for Disease Control and Prevention (CDC) announced a scheduled meeting for the Advisory Board on Radiation and Worker Health, which will take place on April 14 and 15, 2021. This public meeting is designed to discuss updates and issues such as occupational health guidelines and compensation related to radiation exposure at Department of Energy facilities. Space is limited to 200 participants, who can join via audio conference or online. Public comments are encouraged and must be submitted by April 7, 2021, to be included in the official record.

The Centers for Disease Control and Prevention (CDC) is seeking approval from the Office of Management and Budget (OMB) to continue collecting information for the HIV Outpatient Study (HOPS), which observes adults living with HIV in outpatient care across six U.S. cities. The study collects clinical and behavioral data from up to 2,700 participants annually to improve understanding of HIV treatment and related health issues. The CDC welcomes public comments on the necessity and efficiency of this data collection, aiming to minimize response burdens. Participation in the study remains voluntary, with new participants enrolled each year to ensure ongoing data relevance.

The Centers for Disease Control and Prevention (CDC) is asking for public and federal agency comments on a proposed data collection initiative about absenteeism in schools due to influenza-like illnesses and the spread of influenza within student households. This initiative is part of an effort to better understand how influenza spreads in communities, especially from school children to their families, and aims to improve guidelines for future pandemics. Comments must be submitted by April 30, 2021. The CDC highlights that this research could provide valuable insights for public health strategies during pandemics, and the Office of Management and Budget will review the project's necessity and methodology.

The Centers for Disease Control and Prevention (CDC) has issued a notice about a closed meeting. Gregory Anderson, a Scientific Review Officer, is the contact person for more information. This notice allows for the announcement of meetings and other committee activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, the Director of the Strategic Business Initiatives Unit at the CDC, has the authority to sign these notices.

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a draft policy statement regarding biosafety for outdoor large animal studies involving the bacteria Brucella abortus and Brucella suis. This policy aims to guide the development of biosafety plans that comply with regulations set by both the CDC and the U.S. Department of Agriculture (USDA) for research on these bacteria, which pose a threat to human and animal health. The draft policy is available for review, and public comments can be submitted until March 16, 2021, through the provided methods. The policy's goal is to enhance safety protocols for studies on the diseases caused by these bacteria, which affect several animal species and can be transmitted to humans.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This meeting, scheduled for May 11, 2021, will be held via teleconference and will focus on reviewing and evaluating grant applications related to epilepsy incidence and etiology. The meeting is closed to protect confidential information and personal privacy. For more information, the public can contact Jaya Raman, Ph.D., a Scientific Review Officer at the CDC.

The Centers for Disease Control and Prevention (CDC) has submitted a request to revise the Behavioral Risk Factor Surveillance System (BRFSS) for approval by the Office of Management and Budget (OMB), as part of their compliance with the Paperwork Reduction Act of 1995. The BRFSS, which surveys health risk behaviors and conditions across all U.S. states and territories, plans to add an online survey option in addition to traditional phone interviews for 2025-2027. This system helps gather essential health data, and for most states, it's the primary source of such information. Public comments on this proposed data collection are welcome within 30 days of this notice's publication.

The Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose Reconstruction Review (SDRR) is updating information about their upcoming meeting. The meeting, organized by the National Institute for Occupational Safety and Health (NIOSH), will occur on February 25, 2021, and focus on quality management and assurance activities related to dose reconstruction cases. These cases involve various sites, including the Rocky Flats Plant, Hanford, and the Los Alamos National Laboratory, among others. Agenda items are subject to change depending on priorities.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on a proposed information collection related to the National Ambulatory Medical Care Survey (NAMCS) as part of a process for approval by the Office of Management and Budget (OMB). The CDC invites feedback on the necessity and methodology of the survey, ways to enhance the quality and clarity of collected information, and methods to minimize the respondents' burden. The NAMCS provides essential data on ambulatory medical care in the U.S. and aims to sample advanced practice providers, physicians, and health centers over the next few years. Public comments are encouraged within 30 days of this notice's publication.